. i3C NMR data (22.62 MHz, 13, 0, 1, as internal standard; 5 in ppm; JF,c in Hz*). Resistance: e) ANT 4', b) APH 3', °) ANT 4", d) AAD 3", e) ANT 2", f) APH 3", g) AAC 3, h) AAC 6' , ') AAC 2'. nt=Not tested.
VOL. XXXVIII NO. 2 THE JOURNAL OF ANTIBIOTICS in pyridine for 24 hours at 50°C followed by acetylation with acetic anhydride led to 2',3',4', 2",4", 2"'-hexa-O-acetyl-3, 6', 3", 4"'-tetra-N-Boc-6"-O-triphenylmethylamikacin (3, 83%; mp 133 137°C (dec); [a]2D5 69.8° (c 1.1, CHC13) ). Detritylation using boron trifluoride -methanol4) afforded 2',3',4',2",4",2"'-hexa-O-acetyl-3,6',3", 4'--tetra-A'-Boc-amikacin (4, 94%; mp 150-154-C (dec); [a]n -11 -68.0° (c 1.45, CHC13); Rf* 0.41), which on storing in pyridine -H30 (1: 1) at room temp for 2 days formed 2',3',4',2",6",2'--hexa-O-acetyl-3, 6', 3", 4"'-tetra-N-Boc-amikacin (5, 96%; mp 148-151'C (dec); [a]U +64.4° (c 0.41, CHC1,); Rf* 0.60) through O-4"-->6" acetyl migration.'> Reaction of 5 with 1.5 equivalents to trifluoromethane sulfonic anhydride in dichloromethane -pyridine (20: 1) at 0°C for 15 minutes gave 2',3',4',2",6",2"'-hexa-O-acetyl-3, 6',3",4'--tetra-N-Boc-4"-0-trifluoromethylsulfonylamikacin (6, Rf * 0.86), which was treated with sodium azide in DMF -dichloromethane (10: 1) at room temp for 3 hours to yield 2',3',4', 2", 6", 2'--hexa -0-acetyl -4"-azido-3, 6', 3 ", 4"'-tetra-N-Boc-4"-deoxy-4"-epi-amikacin (10, 77%; mp 135-138'C (dec); [a] 2D' +69.7° (c 1.49, CHC13); Rf* 0.84). Reaction of 6, with sodium acetate under the same conditions led to 2',3',4', 2",4",6",2"'-hepta-O-acetyl-3, 6', 3", 4"'-tetra-NBoc-4"-epi-amikacin (12, 79%; mp 150 153°C (dec); [a]21 T78.2° (c2.43, CHCI,); Rf* 0.71). Treatment of 6 with tetra-n-butylammonium fluoride** in acetonitrile at room temp for 3 hours gave 2',3',4',2",6",2"'-hexa-O-acetyl-3,6',3",4"'-tetra-N-Boc-4"-deoxy-4" -fluoro -4"-epi-amikacin (11, 73 %; mp 140 143°C (dec); [a]i° +63.2° (c 0.82, CHCl3); Rf* 0.82).
In all these cases, as previously observed with derivatives of kanamycin A,') a small proportion of the 3"-N,4"-epi-O-cyclic carbamate (Rf* 0.20) was also formed.
Trifluoromethanesulfonylation of 4 gave the 6"-triflate 7 (Rf* 0.80); its reaction with tetra-nbutylammonium fluoride** within half an hour led to 2',3',4',2",4",2"'-hexa-0-acetyl-3,6',3", 4"'-tetra-N-Boc-6"-deoxy-6"-fluoroamikacin (8, 76%; mp 150 153°C (dec); [a]l -65.5° (c 0.96, CHCI,) ; Rf * 0.72).
Zemplen de-O-acetylation of 10, 11, 12 and 8, respectively, followed by treatment with TFA gave the deprotected amikacin derivatives, which were purified by chromatography on Amberlite CG 50 (NH/) with 0.1 -0.3 N ammonia :
4"-Azido-4"-deoxy-4"-epi-amikacin (13) 6"-Deoxy-6"-fluoroamikacin (9), 77%; [a]'' 80.1° (c 1.05, H,O); Rf*** 0.29. As in their verification by 13C NMR spectroscopy all these structural modifications only affected the X"-resonances, the latter only -in comparison with those of the parent amikacin') (1)-are given in Table 1 . Proof for the position of modification results from the 1°F-'3C couplings, whereas the stereochemistry is evident from the chemical shift of C-3".°> MIC values were determined in MuellerHinton broth (Merck 10923) in a microsystem (Dynatech MIC 200, vo150 tul) . Bacterial strains (Sandoz Research Institute culture collection) were stored in liquid nitrogen; the inoculum was prepared immediately after thawing by adjusting the size to 10,' 101 cfu/ml Mueller-Hinton broth. The compounds were dissolved in aqua dest and further diluted by log 2 steps; concentrations are given as the free bases.
The MIC values, summarized in Table 2 , show that 6"-fluorination (9) decreased the activity of amikacin against some strains of Enterobacteriaceae by the factor of 4 to 10. The 4"-derivatives of amikacin, 13, 14 and 15, were remarkably less active than amikacin, in particular against strains provided with the enzymatic resistance mechanism of ANT 4', ANT 4" and AAC 6'. (Received July 16, 1983) 
